Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for liver metastases.

Roman Havlik1, Long R Jiao, Joanna Nicholls

  • 1Liver Surgery Section, Department of Surgical Oncology and Technology, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, London, UK.

Seminars in Oncology
|April 16, 2002
PubMed
Summary

Gene therapy shows promise for liver cancer treatment, with low toxicity observed in clinical trials. However, its current clinical benefit is marginal, suggesting its best use may be alongside traditional therapies for improved outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer Centre Experience.

Cancers·2026
Same author

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026
Same author

A single centre multidisciplinary team retrospective review of fifty cases of robot-assisted surgery for diaphragmatic and thoracic endometriosis.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

GalNAc-conjugated siRNA targeting C/EBPβ reverses metabolic dysfunction and restores liver homeostasis in a murine MASLD model.

Molecular therapy. Nucleic acids·2026
Same author

Small activating RNA AW1-51 (CEBPA-51) elicits targeted DNA demethylation to promote gene activation.

bioRxiv : the preprint server for biology·2025
Same author

A label-free impedimetric immunosensor based on nitrogen-doped graphene acid for sensitive detection of vitamin D<sub>3</sub>.

Mikrochimica acta·2025

Area of Science:

  • Oncology
  • Gene Therapy
  • Hepatology

Background:

  • Resection is the only curative option for metastatic liver cancer, but it is only suitable for a small patient subset.
  • Gene therapy is emerging as a potential alternative treatment for primary and secondary liver cancer.
  • Previous studies have explored various gene types, including tumor-suppressor gene p53, suicide genes, immune genes, and oncolytic adenoviruses.

Purpose of the Study:

  • To evaluate the safety and efficacy of gene therapy in patients with liver cancer.
  • To assess the clinical benefit of gene therapy as a standalone or adjuvant treatment for liver metastases.

Main Methods:

  • Conducted Phase I and II clinical trials involving patients with primary or secondary liver cancer.
  • Administered various gene therapies, including tumor-suppressor gene p53, suicide genes, immune genes, and replication-competent oncolytic adenoviruses.

Related Experiment Videos

Main Results:

  • Gene therapy was generally well-tolerated with low toxicity in clinical trials.
  • The observed clinical benefit of gene therapy for liver cancer has been marginal to date.
  • Gene therapy alone is currently limited as a definitive treatment for liver metastases.

Conclusions:

  • Gene therapy is a safe and tolerable treatment for liver cancer.
  • Further research is needed to enhance the efficacy of gene therapy for liver metastases.
  • Gene therapy may serve as an effective adjuvant treatment when combined with conventional therapies like surgery, chemotherapy, or radiotherapy to improve disease-free survival.